Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials
出版年份 2011 全文链接
标题
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials
作者
关键词
-
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 68, Issue 6, Pages 1575-1583
出版商
Springer Nature
发表日期
2011-05-05
DOI
10.1007/s00280-011-1648-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
- (2012) Alessandro Passardi et al. Journal of Translational Medicine
- Severe interstitial pneumonitis associated with the administration of taxanes
- (2010) Shigeyuki Nagata et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)
- (2009) K. Takeda et al. ANNALS OF ONCOLOGY
- Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
- (2009) Antoaneta Tomova et al. BREAST CANCER RESEARCH AND TREATMENT
- Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
- (2009) Flávio Henrique Ferreira Galvão et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
- (2009) Joaquín Casal Rubio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: Results of a prospective study
- (2009) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer
- (2009) Stephen Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer
- (2009) Silvia Novello et al. LUNG CANCER
- Weekly Docetaxel with or without Gemcitabine as Second-Line Chemotherapy in Paclitaxel-Pretreated Patients with Metastatic Breast Cancer: A Randomized Phase II Study Conducted by the Hellenic Co-Operative Oncology Group
- (2009) Christos A. Papadimitriou et al. ONCOLOGY
- A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer
- (2008) G. Fountzilas et al. BREAST CANCER RESEARCH AND TREATMENT
- Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
- (2008) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- Promising Survival in Patients with Recurrent Non-small Cell Lung Cancer Treated with Docetaxel and Gemcitabine in Combination as Second-Line Therapy
- (2008) Chao Hui Huang et al. Journal of Thoracic Oncology
- Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
- (2008) Se Hoon Park et al. LUNG CANCER
- Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study
- (2008) I. Boukovinas et al. LUNG CANCER
- Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells
- (2008) Gerta Rücker et al. STATISTICS IN MEDICINE
- Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
- (2007) Vassilis Georgoulias et al. LUNG CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation